JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB215206

Anti-FOXP3 antibody [EPR22102-37]

  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • What is this?

5

(5 Reviews)

|

(143 Publications)

Anti-FOXP3 antibody [EPR22102-37] (ab215206) is a rabbit monoclonal antibody detecting FOXP3 in Western Blot, Flow Cytometry (Intra), IP. Suitable for Human, Mouse, Rat.

- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications

View Alternative Names

IPEX, JM2, FOXP3, Forkhead box protein P3, Scurfin

8 Images
Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

Intracellular flow cytometric analysis of4% paraformaldehyde-fixed, 90% methanol-permeabilized HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cell line transfected with a GFP-tagged FOXP3 expression construct labeling FOXP3 with ab215206 at 1/40 dilution (Right) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (Left). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 647) (ab150079), at 1/2000 dilution was used as the secondary antibody.

Multiplex immunohistochemistry - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • mIHC

Collaborator

Multiplex immunohistochemistry - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

10-color fluorescence multiplex immunohistochemical analysis of human lung cancer tissue (formalin-fixed paraffin-embedded section).

Merged staining of anti-FOXP3 (ab215206; Cyan; TG540N), anti-PD1 (ab52587; Red; TG700N), anti-CD163 (ab182422; Brown; TG650N), anti-HLA-DR (ab92511; Yellow; TG570N), anti-CD4 (ab133616; Violet; TG620N), anti-CD8 alpha (ab101500; Purple; TG540S), anti-CD20 (ab9475; Grey; TG660S), anti-CD68 (ab192847; Green; TG520N), anti-Cytokeratin 19 (ab52625; Light blue; TG440N). TG470SN (dark blue) was used as a nuclear counter stain. The inset image shows the separate CD68 signal.

The section was incubated in nine rounds of staining; in the order of ab215206 (1/100 dilution), ab52587 (1/200 dilution), ab182422 (1/300 dilution), ab92511 (1/200 dilution), ab133616 (1/600 dilution), ab101500 (1/300 dilution), ab9475 (1/100 dilution), ab192847 (1/300 dilution), ab52625 (1/400 dilution); each using a separate fluorescent tyramide signal amplification system.

Sodium citrate antigen retrieval (pH6.0) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity.

Image acquisition was performed with TissueFAXS Spectra (TissueGnostics).

This image is courtesy of TissueGnostics Asia Pacific Limited

Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

Human PBMCs were stained with Alexa Fluor® 647 conjugated anti-human CD4 and BV421 conjugated anti-human CD25. Cells were then fixed with 2% PFA for 10min and permeabilized with True-Nuclear™ permeabilization buffer, followed by intracellular staining with rabbit IgG (ab172730, Left) or anti-FOXP3 RabMab (Right, 1/40). ab98462, Dylight®488-conjugated goat anti-rabbit IgG was used as the secondary at a dilution of 1/2000.

Gating strategy and expression pattern is consistent with literature (PMID : 27330808).

Immunoprecipitation - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • IP

Unknown

Immunoprecipitation - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

FOXP3 was immunoprecipitated from 0.35 mg of HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cells transfected with a GFP-tagged FOXP3 expression construct whole cell lysate with ab215206 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab215206 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.

Lane 1 : HEK-293T cells transfected with a GFP-tagged FOXP3 expression construct whole cell lysate 10 μg (Input).
Lane 2 : ab215206 IP in HEK-293T cells transfected with a GFP-tagged FOXP3 expression construct whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab215206 in HEK-293T cells transfected with a GFP-tagged FOXP3 expression construct whole cell lysate (-).

Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.

FOXP3 isoforms have been described in the literature. (PMID : 19568423).

All lanes:

Immunoprecipitation - Anti-FOXP3 antibody [EPR22102-37] (ab215206)

Predicted band size: 47 kDa,90 kDa

Observed band size: 55-73 kDa

false

Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

Rat splenocytes were stained with Alexa Fluor® 647 conjugated anti-rat CD4. Cells were then fixed with 2% PFA for 10min and permeabilized with True-Nuclear™ permeabilization buffer, followed by intracellular staining with rabbit IgG (ab172730, Left) or anti-FOXP3 RabMab (Right, 1/40). ab150077, Alexa Fluor®488-conjugated goat anti-rabbit IgG was used as the secondary at a dilution of 1/2000.

Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

Mouse splenocytes were stained with Alexa Fluor® 647 conjugated anti-mouse CD4. Cells were then fixed with 2% PFA for 10min and permeabilized with True-Nuclear™ permeabilisation buffer, followed by intracellular staining with rabbit IgG (ab172730, Left) or anti-FOXP3 RabMab (Right, 1/40). ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG was used as the secondary at a dilution of 1/2000.

Western blot - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • WB

Unknown

Western blot - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-FOXP3 antibody [EPR22102-37] (ab215206) at 1/1000 dilution

Lane 1:

HEK-293T (human embryonic kidney) transfected with an empty vector (vector control), containing a GFP-myc tag, whole cell lysate at 10 µg

Lane 2:

HEK-293T transfected with FOXP3 (WT) expression vector containing a GFP-myc tag, whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 47 kDa

Observed band size: 73 kDa

false

Exposure time: 6s

Western blot - Anti-FOXP3 antibody [EPR22102-37] (AB215206)
  • WB

Unknown

Western blot - Anti-FOXP3 antibody [EPR22102-37] (AB215206)

Blocking buffer and concentration : 5% NFDM /TBST

Lane 1:

Western blot - Anti-FOXP3 antibody [EPR22102-37] (ab215206) at 1/200 dilution

Lane 2:

Western blot - Anti-FOXP3 antibody [EPR22102-37] (ab215206) at 1/1000 dilution

All lanes:

Full-length C-MYC/DDK tagged Recombinant Mouse Foxp3 protein 10ng

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 47 kDa

Observed band size: 50 kDa

false

Exposure time: 180s

  • Carrier free

    Anti-FOXP3 antibody [EPR22102-37] - BSA and Azide free

  • Carrier free

    Anti- FOXP3 antibody [EPR22102-37] - BSA and Azide free (Capture)

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22102-37

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

<p>We do not guarantee WB for rat.</p><p>According to our preliminary WB data, this antibody failed to detect endogenous expression of FOXP3 in the tissues tested in WB, such as thymus. It might work in CD4+CD25+ Treg cells with abundant FOXP3, but we don't have experimental data to support that.</p>

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "mIHC" : {"fullname" : "Multiplex immunohistochemistry", "shortname":"mIHC"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "mIHC-species-checked": "notRecommended", "mIHC-species-dilution-info": "", "mIHC-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>According to our preliminary WB data, this antibody failed to detect endogenous expression of FOXP3 in the tissues tested in WB, such as thymus. It might work in CD4+CD25+ Treg cells with abundant FOXP3, but we don't have experimental data to support that.</p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "notRecommended", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/40", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "mIHC-species-checked": "notRecommended", "mIHC-species-dilution-info": "", "mIHC-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>According to our preliminary WB data, this antibody failed to detect endogenous expression of FOXP3 in the tissues tested in WB, such as thymus. It might work in CD4+CD25+ Treg cells with abundant FOXP3, but we don't have experimental data to support that.</p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "notRecommended", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/40", "FlowCytIntra-species-notes": "<p></p>" }, "Rat": { "mIHC-species-checked": "notRecommended", "mIHC-species-dilution-info": "", "mIHC-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "notRecommended", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/40", "FlowCytIntra-species-notes": "<p></p>" } } }

Product details

Anti-FOXP3 antibody [EPR22102-37] (ab215206) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), IP, WB in human, mouse, rat samples.

Anti-FOXP3 antibody [EPR22102-37] (ab215206) has been cited over 67 times in peer reviewed journals and is trusted by the scientific community.

Abcams high quality manufacturing and validation processes ensure Anti-FOXP3 antibody [EPR22102-37] (ab215206) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

Anti-FOXP3 antibody [EPR22102-37] (ab215206) has 5 independent reviews from customers.

Anti-FOXP3 antibody [EPR22102-37] (ab215206) specifically detects FOXP3 (UniProt ID: Q9BZS1; Molecular weight: 47kDa) and is sold in a convenient trial size to enable initial testing (20 uL) and larger sizes for subsequent scaling up experiments (100 uL and 1 mL).

Conjugation-ready, carrier free format available for antibody clone EPR22102-37 - ab244242.

FOXP3 is a key transcription factor that regulates the development and function of regulatory T cells (Tregs), which help maintain immune tolerance. In oncology, high FOXP3 expression is often linked to poor prognosis as it can enable tumors to evade the immune system. This makes FOXP3 a potential biomarker for predicting the effectiveness of immunotherapy treatments.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FOXP3 also recognized as Forkhead box P3 is a transcription factor critical for immune system function. It weighs approximately 47 kDa. FOXP3 is mainly expressed in regulatory T cells (Tregs) which play a role in maintaining immune tolerance. Scientists primarily identify its presence in the nucleus where it facilitates transcriptional regulation. Methods like 'FOXP3 IHC' and 'FOXP3 IHC mouse' are useful for detecting this protein in tissue samples while 'FOXP3 antibodies' aid in research on this target. Techniques like 'FOXP3 staining' and 'FOXP3 flow cytometry' further allow for the analysis of its expression and function.
Biological function summary

This transcription factor operates by regulating the expression of a variety of genes involved in Treg cell development and function. FOXP3 can interact with other proteins to form complexes that modulate gene expression. Its role is essential in enabling Tregs to suppress immune responses a process necessary for preventing autoimmunity. The interaction extends to other key regulators within Tregs such as the protein complex 221D which may have overlapping functional responsibilities. 'FOXP3 236a/E7' reflects its genetic variants detectable in different studies providing insights into its biological functions.

Pathways

FOXP3 is a significant player within the immune regulation pathway. It integrates into the TGF-beta signaling pathway in which it controls the expression of genes important for Treg functions. The protein recruits other transcription factors like NF-kB coordinating intricate network regulations within immune cells. FOXP3's activity orchestrates the balance between immune activation and suppression ensuring a well-functioning immune response that prevents overreactions leading to autoimmune conditions.

FOXP3 mutations or dysregulation can link to autoimmune diseases like immune dysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX). This transcription factor's malfunction implicates cancer where inadequate Treg function can either suppress antitumor immunity or result in tumor progression. Proteins such as CTLA-4 which is also involved in immune regulation connect to FOXP3 in these contexts emphasizing FOXP3’s significant role in maintaining immune homeostasis and its impact on disease development.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg) (PubMed : 17377532, PubMed : 21458306, PubMed : 23947341, PubMed : 24354325, PubMed : 24722479, PubMed : 24835996, PubMed : 30513302, PubMed : 32644293). Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells (PubMed : 23169781). Can act either as a transcriptional repressor or a transcriptional activator depending on its interactions with other transcription factors, histone acetylases and deacetylases (PubMed : 17377532, PubMed : 21458306, PubMed : 23947341, PubMed : 24354325, PubMed : 24722479). The suppressive activity of Treg involves the coordinate activation of many genes, including CTLA4 and TNFRSF18 by FOXP3 along with repression of genes encoding cytokines such as interleukin-2 (IL2) and interferon-gamma (IFNG) (PubMed : 17377532, PubMed : 21458306, PubMed : 23947341, PubMed : 24354325, PubMed : 24722479). Inhibits cytokine production and T-cell effector function by repressing the activity of two key transcription factors, RELA and NFATC2 (PubMed : 15790681). Mediates transcriptional repression of IL2 via its association with histone acetylase KAT5 and histone deacetylase HDAC7 (PubMed : 17360565). Can activate the expression of TNFRSF18, IL2RA and CTLA4 and repress the expression of IL2 and IFNG via its association with transcription factor RUNX1 (PubMed : 17377532). Inhibits the differentiation of IL17 producing helper T-cells (Th17) by antagonizing RORC function, leading to down-regulation of IL17 expression, favoring Treg development (PubMed : 18368049). Inhibits the transcriptional activator activity of RORA (PubMed : 18354202). Can repress the expression of IL2 and IFNG via its association with transcription factor IKZF4 (By similarity).
See full target information FOXP3

Publications (143)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in microbiology 16:1565392 PubMed41035878

2025

Gastric mucosal proteomic analysis reveals the role of the TGF- signaling pathway in gastritis associated with infection.

Applications

Unspecified application

Species

Unspecified reactive species

Chengjie Zhu,Lijuan Xiong,Yun He,Chaoqin Sun,Fei Mo

Blood and lymphatic cancer : targets and therapy 15:167-179 PubMed40951454

2025

Comprehensive Analysis of Tumor Microenvironment and PD-L1 Expression Associations with Clinicopathological Features and Prognosis in Diffuse Large B-Cell Lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yun-Li Xie,Long-Feng Ke,Wen-Wen Zhang,Fu Kang,Shu-Yi Lu,Chen-Yu Wu,Huan-Huan Zhu,Jian-Chao Wang,Gang Chen,Yan-Ping Chen

Cell reports. Medicine 6:102217 PubMed40834855

2025

Genomic landscape and immunological profile of glioblastoma in East Asian patients.

Applications

Unspecified application

Species

Unspecified reactive species

Sheng Zhong,Bo Wu,Frank Dubois,Davy Deng,Johann S Bergholz,Wanming Hu,Hao Duan,Yujie Shao,Jingyi Liu,Luwei Liu,Sitong Chen,Yongfei Hu,Zheng Zhao,Maojin Yao,Ke Sai,Jian Wang,Yinsheng Chen,Chao Ke,Xiangheng Zhang,Qunying Yang,Chengcheng Guo,Ji Zhang,Fuhua Lin,Zhenghe Chen,Deipei Li,Zhenqiang He,Chang Li,Xiaobing Jiang,Jie Lu,Wenzhuo Yang,Tao Jiang,Zhongping Chen,Rameen Beroukhim,Jean J Zhao,Yonggao Mou

Clinical & translational immunology 14:e70048 PubMed40672112

2025

SIRT7 ameliorates Th17/Treg imbalance by desuccinylation of STAT3 to improve immune thrombocytopenia.

Applications

Unspecified application

Species

Unspecified reactive species

Jiao Ge,Xiaoyan Zhang,Fajuan Tang,Yan Liu

Cancer cell international 25:225 PubMed40544264

2025

Comprehensive analysis of single-cell and bulk RNA sequencing data unveils antigen-presenting and processing fibroblasts and establishes a predictive model in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chenggang Zhang,Fangqi Chen,Jie Li,Yixuan He,Juan Sun,Zicheng Zheng,Guanmo Liu,Yihua Wang,Weiming Kang,Xin Ye

Cell reports. Medicine 6:102190 PubMed40532664

2025

Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Run-Cong Nie,Xiao-Jiang Chen,Cheng-Cai Liang,Bai-Wei Zhao,Wei Wang,Fei-Yang Zhang,Mu-Yan Cai,Hai-Bo Qiu,Zhi-Cheng Xue,Guo-Ming Chen,Zhi-Min Liu,Jun Chi,Jin-Ling Duan,Dong-Sheng Zhang,Ying-Bo Chen,Zhi-Wei Zhou,Yong-Ming Chen,Shu-Qiang Yuan,Yuan-Fang Li

Journal of translational medicine 23:679 PubMed40533802

2025

The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Zhou,Guangzu Cui,Erya Hu,Xinwen Wang,Diya Tang,Xiangyang Zhang,Jiayao Ma,Yin Li,Haicong Liu,Qingping Peng,Ying Han,Yihong Chen,Shan Zeng,Yan Zhang,Hong Shen

BMC pulmonary medicine 25:283 PubMed40483449

2025

Impact of irae characteristics on efficacy of consolidative immunotherapy following chemoradiotherapy in locally advanced NSCLC.

Applications

Unspecified application

Species

Unspecified reactive species

Xiufen Wang,Xuebing Fu,Qiaohong Liu,Juan Li,Yihui Ge,Jian Zhang,Shuyun Wang,Leirong Wang,Dahai Wang,Yanxin Sun,Yiling Gan,Haodong Sun,Zhen Wang,Yuping Sun,Aiqin Gao

Frontiers in oncology 15:1552480 PubMed40444091

2025

Study on the mechanism by which Xuanfu Hua Tang increases sensitivity of hepatocellular carcinoma cells to sorafenib by antagonizing the Notch1 pathway through HIF-2α.

Applications

Unspecified application

Species

Unspecified reactive species

Wenzhao Luo,Xian Li,Yiwan Shang,Zhen Chen,Yinglin Cui

Journal of translational medicine 23:478 PubMed40281576

2025

scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ziqi Huang,Li Li,Xiaohe Zhao,Haixia Jin,Meng Shen,Baihui Li,Yu Zeng,Qinfen Zhang,Qiyu Wang,Meng Wang,Lili Yang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com